iNtRON Biotechnology, Inc. (KOSDAQ: 048530)

iNtRON Biotechnology Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 11, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	186,868	291,422	269,879	709,999	915,063	464,141
Market Cap Growth	-1.89%	7.98%	-61.99%	-22.41%	97.15%	-28.07%
Enterprise Value	130,778	224,880	175,332	642,575	858,619	409,732
Last Close Price	5630.00	8780.00	8035.13	20804.38	27525.03	15319.14
PE Ratio	-	-30.06	-23632.75	72.24	70.74	-89.85
PS Ratio	20.76	30.40	19.27	24.23	20.14	55.60
PB Ratio	2.06	3.01	2.54	7.01	10.72	7.14
P/FCF Ratio	-35.42	-62.36	72.00	52.88	401.50	-417.07
P/OCF Ratio	128.77	93.48	45.15	43.10	128.32	-571.26
EV/Sales Ratio	14.41	23.46	12.52	21.92	18.90	49.08
EV/EBITDA Ratio	-136.16	-163.75	1999.29	55.33	49.62	-139.15
EV/EBIT Ratio	-47.69	-68.46	-118.54	63.76	54.56	-93.80
EV/FCF Ratio	-22.37	-48.12	46.78	47.86	376.74	-368.18
Debt / Equity Ratio	0.00	0.00	0.29	0.45	0.12	0.23
Debt / EBITDA Ratio	-	-	356.59	3.94	0.59	-
Debt / FCF Ratio	-0.07	-0.09	8.34	3.41	4.51	-13.54
Asset Turnover	0.08	0.08	0.10	0.23	0.48	0.12
Inventory Turnover	3.60	4.20	4.89	6.01	13.19	3.31
Quick Ratio	41.91	76.13	3.50	3.73	6.16	15.50
Current Ratio	43.03	77.59	3.54	3.77	6.40	16.10
Return on Equity (ROE)	-6.22%	-9.56%	5.50%	10.42%	19.88%	-6.12%
Return on Assets (ROA)	-1.69%	-1.71%	-0.63%	4.96%	10.38%	-3.80%
Return on Capital (ROIC)	-1.71%	-1.75%	-0.65%	5.19%	11.19%	-4.43%
Earnings Yield	-3.23%	-3.33%	2.12%	1.37%	1.63%	-0.69%
FCF Yield	-3.13%	-1.60%	1.39%	1.89%	0.25%	-0.24%
Dividend Yield	1.76%	1.14%	-	-	-	-
Buyback Yield / Dilution	0.23%	2.16%	-0.58%	4.41%	-6.08%	-7.42%
Total Shareholder Return	1.99%	3.30%	-0.58%	4.41%	-6.08%	-7.42%

Source: S&P Capital IQ. Standard template. Financial Sources.